Braña M F, Castellano J M, Morán M, Pérez de Vega M J, Perron D, Conlon D, Bousquet P F, Romerdahl C A, Robinson S P
Universidad San Pablo-CEU, Departamento de Química Orgánica y Farmacéutica, Madrid, Spain.
Anticancer Drug Des. 1996 Jun;11(4):297-309.
The bis-naphthalimides are a new class of antitumor agent. Previously, we have described initial synthetic series which established that two naphthalimide chromophores joined by polyamine linkers can produce agents with antitumor activity. We now extend these studies to describe the synthesis of a N,N'-bis[1,8-naphthalimido)-ethyl]alkanediamine series and examine the alkyl linker and chromophore substitution requirements for optimal antitumor activity. As a result, a bis-naphthal-imidoethyl derivative with no chromophore substitution and a NH-(CH2)3-NH bridge was identified. This agent (LU 79553) had both potent cellular cytotoxicity (IC50 = 0.014 microM) and was curative against MX-1 tumors grown in athymic mice. It has now been selected for clinical development.
双萘二甲酰亚胺是一类新型抗肿瘤药物。此前,我们已经描述了初步的合成系列,该系列证实通过多胺连接子连接的两个萘二甲酰亚胺发色团可产生具有抗肿瘤活性的药物。我们现在扩展这些研究,以描述N,N'-双[1,8-萘二甲酰亚胺基)-乙基]链烷二胺系列的合成,并研究烷基连接子和发色团取代对最佳抗肿瘤活性的要求。结果,鉴定出一种没有发色团取代且具有NH-(CH2)3-NH桥的双萘二甲酰亚胺乙基衍生物。该药物(LU 79553)具有强大的细胞毒性(IC50 = 0.014微摩尔),并且对无胸腺小鼠体内生长的MX-1肿瘤具有治愈作用。它现已被选入临床开发阶段。